Alexandra Sowa, metabolic medicine specialist, author of The Ozempic Revolution and founder of SoWell, to build on these
some preclinical and early research has suggested possible expression in skin-associated cells, though this evidence is not yet well established in humans and should be regarded as hypothesis-generating rather than confirmed
Updated September 17, 2024
Expect 1020% potency loss per freeze-thaw cycle
By inhibiting oxidative phosphorylation (OXPHOS), which induces mitochondrial hyperpolarization and subsequently stimulates ROS production [23], the oxidation of palmitoylcarnitine (C16-carnitine) produces more ROS in mitochondria than carbohydrates [24]
Therefore, the proper maintenance of redox homeostasis can potentially serve as a rational therapeutic strategy to protect against OA progression